Ernst & Young
Fraud Investigation & Dispute Services, Life Sciences team

Tighter competition, regulatory scrutiny and tough enforcement heighten the risk of litigation and non-compliance. In your industry, compliance issues and risk factors need to be addressed at every turn from research and development to marketing strategies and supply chain integrity. And the scrutiny of regulators and customers alike is increasing and rapidly changing. Focused on your industry. Our professionals understand the complex issues facing pharmaceutical, biotechnology and medical device companies. We have established experience helping companies evaluate and manage those aspects of their businesses that pose the greatest potential risks. Our dedicated team includes CPAs, government contract analysts, economists, licensed pharmacists and certified fraud examiners, as well as former pharmaceutical executives, ethics and compliance officers and government auditors, investigators and prosecutors.

For more information visit www.ey.com/us/fids or contact Ted Acosta, Principal, Fraud Investigation & Dispute Services, Life Sciences Leader, (212) 773-3022.

PwC
PwC's Pharmaceutical and Life Sciences Industry Group is dedicated to delivering effective solutions to the complex strategic, operational and financial challenges facing pharmaceutical, biotechnology and medical device companies. We provide industry-focused assurance, tax and advisory services to build public trust and enhance value for our clients and their stakeholders. More than 163,000 people in 151 countries across our network share their thinking, experience and solutions to develop fresh perspectives and practical advice. For more information visit www.pwc.com/pharma and www.pwc.com/medtech, contact Marina Bello Valcarce, +44 207 212 8642.

AHM
AHM is the leading global provider of technology-enabled services designed to manage compliant interactions with healthcare professionals for the highly regulated pharmaceutical, biotech and medical device industries. Our patented systems are installed with the top global pharmaceutical and biotech companies and used by tens of thousands of industry sales representatives, managers and healthcare professionals. For more information visit www.ahmdirect.com or contact Wayne Baker, Sr. Vice President & Chief Sales Officer, (908) 393-8820.

Baker & McKenzie
Baker & McKenzie's involvement in the pharmaceutical, healthcare and medical industry stretches over 50 years. During this time, our lawyers have developed a depth of knowledge in the industry in respect of various market players including manufacturers, distributors, research institutions, clinical trial bases and health and regulatory authorities. In addition to our lawyers within the Asia Pacific region, the team includes registered pharmacists and electrical and mechanical engineers.

Baker & McKenzie has a legal network spanning 71 locations in 44 countries. With our expansive global footprint the pharmaceutical, healthcare and medical group has a strong understanding of the changing regulations regarding product registration, market access, trade promotion, product liability, labeling and advertising restrictions and other issues that affect market players in the developing Asian market.

For more information, please visit www.bakermckenzie.com, or contact Peerapan Tungsuwan, Chair Asia Pacific Pharmaceuticals & Healthcare Industry Group, +66 2 636 2000 ext. 4334.

Cegedim
Cegedim Relationship Management is the Life Sciences industry's leading provider of Customer Relationship Management (CRM) and Business Compliance solutions in more than 80 countries. Given the recent enactment of diverse regulatory and disclosure regulations across every market, the pharmaceutical industry is focused on mitigating reputational risks, fines and possible court cases associated with bribery and corruption. However, achieving compliance monitoring and reporting becomes a complex challenge, not to mention costly.

Aggregate Spend 360, Cegedim Relationship Management's pro-active, web-based application, automates and streamlines the tracking and reporting of all expenditures between Life Sciences companies and healthcare professionals per local and global transparency requirements - such as the US Patient Protection and Affordable Care Act (Sunshine Act), the French Law and Japan and Australian voluntary guidelines. It can also support the implementation of adequate procedures to address anti-bribery regulations - such as the UK Bribery Act and Foreign Corrupt Practices Act. This process can be leveraged by accurate customer data management and the integration of a wide range of enterprise applications - CRM, ERP, Finance, Travel & Expense and HR - for in-depth analysis and improved insight. For more information visit www.cegedim.com/rm.

Clifford Chance
Clifford Chance is one of the world's leading law firms, helping clients achieve their goals by combining the highest global standards with local expertise.

Our Global Healthcare and Life Sciences team was established in the early 1990s and now consists of more than 80 dedicated lawyers in 30 key centres worldwide. Having cultivated an expertise in the industry over nearly two decades and worked with many of the world's leading pharmaceutical, biotechnology, medical device and health care services companies, we understand the importance of anticipating regulatory and contractual issues in the context of corporate investment, finance, strategy and operations. We have close relations with a number of multi-nationals as well as national and international trade associations in the pharmaceutical and medical device industries.

In China, we were one of the first international law firms to receive a license in Shanghai in 1993, and our lawyers have operated in Beijing (since 1985) and Hong Kong (since 1980). As one of the largest platforms of any foreign law firm in China, Clifford Chance today offers comprehensive advice from professionals with two decades of on-the-ground legal experience in mainland China. Our Greater China team of over 200 lawyers are based in Beijing, Shanghai and Hong Kong and provide local and global expertise in corporate/M&A, capital markets, banking and finance, real estate, employment, intellectual property, antitrust, anti-corruption and dispute resolution in the region.

Globally, Clifford Chance has 34 offices in 24* countries and over 3,350 legal advisors. (*The Firm also has a co-operation agreement with Al-Jadaan & Partners Law Firm in Riyadh.)

For more information, please visit www.CliffordChance.com or contact Emma Davies, Partner, China, +86 21 2320 7215.

Davis Wright Tremaine
Those of us in the Davis Wright Tremaine health care practice group devote nearly all of our time to industry-specific matters. This allows us to develop niche practices within the field that serve needs unique to the health care market. We also understand the business issues and regulatory developments that affect health care delivery and compliance, and as a unified team we can match the attorney with the niche expertise that best addresses client needs. For more information visit our website at www.DWT.com.

Hogan Lovells
Hogan Lovells provides high quality advice to corporations, financial institutions, and governmental entities across the full spectrum of their critical business and legal issues globally and locally. Bringing together the combined strengths of our predecessor firms, we have over 2,300 lawyers operating out of more than 40 offices in the United States, Latin America, Europe, the Middle East, and Asia. With more than 100 lawyers serving the pharmaceutical and biotechnology sectors, including many with experience at FDA, CMS and other key government agencies, as well as others holding advanced degrees in relevant disciplines, we offer timely, effective counsel on matters that include product development, approval and post-approval compliance, and the development of next-generation products. High rankings in Chambers, PLC Which Lawyer?, and other global directories speak to the quality and impact of our services.

Whether your products are traditional drugs or biotechnology products, we work with you to successfully develop and commercialize products, addressing issues of regulatory approvals and compliance; coverage, reimbursement, and pricing; and careful use of intellectual property and regulatory exclusivities to manage product life cycles. Our multidisciplinary team leverages the skills and experience of colleagues in other disciplines - including healthcare compliance (such as coverage, reimbursement, pricing, and fraud and abuse prevention), public policy, intellectual property, corporate and securities law, and litigation - to provide integrated, strategic, and practical advice for successful product development and marketing and effective responses to regulators and competitors.

For more information, visit www.hoganlovells.com or contact Senior Marketing Coordinator Emily Schoenfelder at (202) 637-8688.

KPMG
With deep industry experience, insight, and technical support, KPMG is one of the largest providers of audit, tax, and advisory services to pharmaceutical and life sciences companies. We help clients gain practical insight into emerging issues, consider approaches to balance risk and controls, improve performance, and explore the accelerating transformation of this industry, both domestically and globally. For more information about KPMG China, please visit us at www.kpmg.com.cn or call 86-21-2212-2888.

Sidley Austin
Sidley Austin LLP is a premier law firm with an internationally recognized life sciences practice, representing major pharmaceutical, biotechnology, medical device, diagnostics, dietary supplements and food clients. Sidley consistently ranks among the top firms in Asia, Europe and the U.S., and is the only law firm with top tier life sciences rankings across three continents in the PLC Cross-border Life Sciences Handbook 2012. Many lawyers on our team are acknowledged leaders in their field. Sidley was the first international law firm to establish a stand-alone, comprehensive food and drug regulatory practice in China. With more 30 years experience and six offices in Asia, our lawyers advise life sciences clients in every aspect of their business operations, including regulatory and compliance, corporate and M&A, government enforcement, FCPA, antitrust and others. For more information visit www.Sidley.com or contact Chen Yang at 86-10-5905 5600 or Thomas Albrecht at 852-2509 7607.

Seton Hall Law
The Center for Health & Pharmaceutical Law & Policy advances scholarship and recommendations for policy on the varied and complex issues posed by health and pharmaceutical law. The Center fosters informed dialogue between policymakers, consumer advocates, the medical profession, and industry in the search for solutions to the ethical, legal and social questions presented in the health and pharmaceutical arena.

In addition, the Center is a leader in providing healthcare compliance education and training in the U.S. and Europe on national and international mandates that apply to the safety and promotion of drugs and devices. The Center also hosts conferences and educational programs, inviting leading experts from the public and private sectors to examine cutting edge policy issues.

Launched in April 2007, the Center extends Seton Hall Law School's national reputation in health law to the life sciences arena and offers a challenging health law curriculum through its M.S.J., J.D. and LL.M. degree programs and online Graduate Certificates. The Center operates under the leadership of a full-time Executive Director, Simone Handler-Hutchinson, and draws upon the intellectual strength of the Seton Hall Law School faculty and research fellows who bring to the Center's work nationally recognized expertise in health and pharmaceutical law, not-for-profit governance, intellectual property law and bioethics, among other areas.

For further information or inquiries about the Center and its varied programs, please visit the website at law.shu.edu/CenterforHealth and law.shu.edu/compliance, or contact Simone Handler-Hutchinson, Executive Director of the Center.